As European markets continue to show resilience with the STOXX Europe 600 Index posting its longest streak of weekly gains since August 2012, investors are keenly observing the mixed economic signals from major economies like Germany and France. In this context, identifying undervalued stocks becomes crucial for those looking to capitalize on potential growth opportunities amidst ongoing economic uncertainties and inflation concerns.
Name | Current Price | Fair Value (Est) | Discount (Est) |
Sword Group (ENXTPA:SWP) | €32.70 | €63.90 | 48.8% |
Laboratorios Farmaceuticos Rovi (BME:ROVI) | €53.90 | €107.22 | 49.7% |
Schoeller-Bleckmann Oilfield Equipment (WBAG:SBO) | €32.00 | €62.72 | 49% |
TF Bank (OM:TFBANK) | SEK367.00 | SEK717.47 | 48.8% |
Hybrid Software Group (ENXTBR:HYSG) | €3.58 | €7.05 | 49.2% |
Tubacex (BME:TUB) | €3.905 | €7.64 | 48.9% |
CD Projekt (WSE:CDR) | PLN216.00 | PLN428.55 | 49.6% |
Storytel (OM:STORY B) | SEK90.35 | SEK177.35 | 49.1% |
Cint Group (OM:CINT) | SEK6.53 | SEK12.94 | 49.5% |
u-blox Holding (SWX:UBXN) | CHF72.80 | CHF143.72 | 49.3% |
Click here to see the full list of 204 stocks from our Undervalued European Stocks Based On Cash Flows screener.
Let's uncover some gems from our specialized screener.
Overview: Tinexta S.p.A., along with its subsidiaries, offers digital trust, cybersecurity, and business innovation services to professionals, institutions, and businesses both in Italy and internationally, with a market cap of €371.72 million.
Operations: The company's revenue is derived from three primary segments: Cybersecurity (€97.29 million), Digital Trust (€202.20 million), and Business Innovation (€141.14 million).
Estimated Discount To Fair Value: 48.5%
Tinexta is trading significantly below its estimated fair value, with a share price of €8.1 compared to a fair value of €15.74, indicating potential undervaluation based on cash flows. Despite this, the company's dividend yield of 5.68% is not well covered by earnings due to large one-off items impacting financial results and debt not being fully covered by operating cash flow. However, Tinexta's revenue and earnings are forecasted to grow faster than the Italian market over the next few years.
Overview: Zinzino AB (publ) is a direct sales company that offers dietary supplements and skincare products both in Sweden and internationally, with a market cap of SEK4.88 billion.
Operations: The company's revenue segments include SEK182.15 million from Faun and SEK2.11 billion from Zinzino (including VMA Life).
Estimated Discount To Fair Value: 47%
Zinzino is trading at a substantial discount to its estimated fair value, with a share price of SEK 140 compared to an estimated fair value of SEK 264.22. Despite recent insider selling, the company shows promising growth prospects with earnings forecasted to grow faster than the Swedish market at 14.7% annually. Zinzino's revenue increased significantly in January 2025 and its dividend proposal reflects confidence in future cash flows, though earnings growth remains moderate.
Overview: Semperit Aktiengesellschaft Holding is a company that develops, produces, and sells rubber products for the medical and industrial sectors globally, with a market cap of €288.44 million.
Operations: The company's revenue segments include Semperit Engineered Applications with €380.82 million, Semperit Industrial Applications at €288.16 million, and Surgical Operations generating €34.32 million.
Estimated Discount To Fair Value: 44.6%
Semperit Holding is trading at €14.02, significantly below its estimated fair value of €25.3, indicating potential undervaluation based on cash flows. Despite a dividend yield of 3.57%, it's not well covered by free cash flows, raising sustainability concerns. Earnings are forecast to grow substantially at 34.7% annually, outpacing the Austrian market's growth rate of 9.3%. However, profit margins have decreased from last year and return on equity is projected to remain low at 5.9%.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
Companies discussed in this article include BIT:TNXT OM:ZZ B and WBAG:SEM.
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com
免責聲明:投資有風險,本文並非投資建議,以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請,作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考,不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證,投資者應自行研究並在投資前尋求專業建議。